Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetes
published in: Diabetes Care
date of publication: 2015-01-12
language: English
main subject: type-1 diabetes, autoantibody
Cites articles 38
Date
Title
Article - wd:Q35207904